October 2022
Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF
This conference focused on the next steps for improving women’s health outcomes and service delivery.
It was an opportunity to examine the recently published Women’s Health Strategy for England - and what will be necessary if the ambitions it outlines are to be achieved in the focus areas of menstrual and gynaecological health, fertility and pregnancy, menopause, long-term conditions, and the impacts of violence on health.
We also expected wider discussion on priorities for Government policy under the new Prime Minister.
We are pleased to have been able to include keynote addresses from:
- Professor Dame Lesley Regan, Professor of Obstetrics and Gynaecology, Imperial College London - who has been appointed as the DHSC’s Ambassador for Women’s Health to support the implementation of the strategy and to help drive efforts to reduce the gender health gap
- Dr Edward Morris, President, Royal College of Obstetricians and Gynaecologists
- Professor Shakila Thangaratinam, Professor of Perinatal and Maternal Health and Joint Director of WHO Global Collaborating Centre for Women’s Health, University of Birmingham; and Founder, Dame Hilda Lloyd Network
Overall areas for discussion included:
- the strategy - scope and emphasis - implementation - the leadership and accountability to achieve progress
- service development - improving diagnosis - integration - tackling variation in access and other areas of inequality
- stigma - improvement of the first points of contact in primary care
- sexual and reproductive health - care and support across the life cycle - diagnosis rates - accessibility of services and information - patient-centred approaches
- research - areas of focus for women’s health - improving the data and the evidence base
- inequalities - tackling disparities in health outcomes - building a responsive environment for women’s health concerns
- workforce education - priorities for development and a focus on women’s health issues
The discussion brought together stakeholders with key policy officials who attended from the DHSC; MHRA; Cabinet Office; DCMS; Department of Health, Ireland; and The Scottish Government - as well as parliamentary pass-holders from the House of Lords.
